Reducing Treatment Burden in IBD with At-Home Therapy Options - Episode 2
Efficacy and Safety of Subcutaneous Infliximab
Published on:
A key opinion leader analyzes the clinical remission and endoscopic response data from the LIBERTY CD and LIBERTY UC trials for subcutaneous infliximab-dyyb injection, contrasts it with intravenous infliximab, and evaluates the drug's safety and efficacy profile.
- What are the key findings regarding the clinical remission and endoscopic response of subcutaneous infliximab-dyyb injection from the LIBERTY CD and LIBERTY UC trials?
- How does subcutaneous infliximab injection compare to IV infliximab in terms of sustenance of drug levels?
- Are there any clinical advantages of the subcutaneous delivery over the IV route?
- How does the safety profile of subcutaneous infliximab injection compare to IV infliximab?
